Exact Mass: 463.0641

Exact Mass Matches: 463.0641

Found 20 metabolites which its exact mass value is equals to given mass value 463.0641, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Adenylsuccinic acid

(2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.074)


Adenylsuccinic acid, also known as adenylosuccinate, succinyladenosine or aspartyl adenylate, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenylsuccinic acid is found in all living organisms, ranging from bacteria to plants to animals. Adenylsuccinic acid is an important intermediate in the de novo purine biosynthesis pathway. Specifically, adenylsuccinic acid is an intermediate in the interconversion of purine nucleotides inosine monophosphate (IMP) and adenosine monophosphate (AMP). The enzyme adenylosuccinate synthase carries out the reaction by the addition of aspartate to IMP. This reaction requires the input of energy from a phosphoanhydride bond in the form of guanosine triphosphate (GTP). Adenylsuccinic acid is a substrate least one other important metabolic reaction in purine biosynthesis. In particular, adenylsuccinic acid can be converted into fumaric acid through its interaction with the enzyme known as adenylosuccinate lyase (or adenylosuccinase). Adenylosuccinate lyase deficiency, is a rare autosomal recessive metabolic disorder characterized by the appearance of succinylaminoimidazolecarboxamide riboside (SAICA riboside) and adenylsuccinic acid in cerebrospinal fluid and urine (PMID: 8412002). Adenylosuccinate lyase deficiency presents with varying degrees of psychomotor retardation, autism, muscle wasting, and epilepsy. The exact cause of the symptoms is unknown, but possibilities include not enough purine nucleotide synthesis for cell replication, malfunctioning of the purine nucleotide cycle, and a buildup of substrates to toxic levels. Adenylsuccinic acid is a substrate of the enzyme adenylosuccinase [EC 4.3.2.2] in purine metabolism pathway. The accumulation of adenylsuccinic acid in body fluids occurs due to a deficiency of adenylosuccinase. (KEGG; PMID 8412002) [HMDB] D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids KEIO_ID A037; [MS2] KO008839 KEIO_ID A037; [MS3] KO008840 KEIO_ID A037

   

[(3S)-1-Azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2-(4-iodophenyl)-2-phenylacetate

[(3S)-1-Azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2-(4-iodophenyl)-2-phenylacetic acid

C21H22INO3 (463.0644)


   

Adenylosuccinic acid

2-[(9-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-9H-purin-6-yl)amino]butanedioic acid

C14H18N5O11P (463.074)


   

6-Methylthio-3-oxohexyl glucosinolate

6-Methylthio-3-oxohexyl glucosinolate

C14H25NO10S3 (463.0641)


   

Adenylsuccinic acid

Adenylosuccinic acid

C14H18N5O11P (463.074)


   

Chondritinsulfate

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylicacid

C13H21NO15S (463.0632)


   

2-METHOXYETHYL 2-(5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROPHENOXY)PROPANOATE

2-METHOXYETHYL 2-(5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROPHENOXY)PROPANOATE

C19H17ClF3NO7 (463.0646)


   

5-[4-benzoyl-2,3-bis[(6-diazonio-5-oxidonaphthalen-1-yl)sulfonyloxy]phenoxy]sulfonyl-2-diazonionaphthalen-1-olate

5-[4-benzoyl-2,3-bis[(6-diazonio-5-oxidonaphthalen-1-yl)sulfonyloxy]phenoxy]sulfonyl-2-diazonionaphthalen-1-olate

C23H15N2O7S+ (463.06)


   

chondroitin sulfate

chondroitin sulfate

C13H21NO15S (463.0632)


   

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

C27H18BrN3 (463.0684)


   

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

C27H18BrN3 (463.0684)


   

CHONDROITIN SULFATE SHARK CARTILAGE(RG)

CHONDROITIN SULFATE SHARK CARTILAGE(RG)

C13H21NO15S (463.0632)


   

Chondroitin 4-sulfate

Chondroitin 4-sulfate

C13H21NO15S (463.0632)


   

Aspartyl adenylate

Aspartyl adenylate

C14H18N5O11P (463.074)


D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids

   

4-amino-N-[2-[[5-bromo-2-[(2-fluorophenyl)methoxy]phenyl]methylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide

4-amino-N-[2-[[5-bromo-2-[(2-fluorophenyl)methoxy]phenyl]methylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide

C19H19BrFN5O3 (463.0655)


   

N(6)-(1,2-dicarboxyethyl)-AMP

N(6)-(1,2-dicarboxyethyl)-AMP

C14H18N5O11P (463.074)


The N(6)-(1,2-dicarboxyethyl) derivative of adenosine 5-monophosphate.

   

6-({2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-({2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H21NO15S (463.0632)


   

(2s,3s,4s,5r,6r)-6-{[(2r,3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(2r,3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H21NO15S (463.0632)


   

1-carboxy-4-(4,5-dihydroxy-1-oxidoquinolin-1-ium-2-yl)-3,6-dihydroxy-5-oxo-5h-5λ⁵-phenazin-5-ylium-10-olate

1-carboxy-4-(4,5-dihydroxy-1-oxidoquinolin-1-ium-2-yl)-3,6-dihydroxy-5-oxo-5h-5λ⁵-phenazin-5-ylium-10-olate

C22H13N3O9 (463.0652)


   

(2r)-2-({9-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]purin-6-yl}amino)butanedioic acid

(2r)-2-({9-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.074)